位置: Shanghai, China
日期：
活動詳細資訊: CHINATRIALS 2025 brings together global and regional leaders shaping the future of clinical research and biotech innovation, spanning early pipeline strategy, cross-border clinical development, and strategic partnerships. As a leading Asia-Pacific CRO and trusted global partner, Novotech will participate in two sessions on 13 November: Novotech Participation (13 November): Moderator: Helen Jiang, Chief Medical Officer, Shanghai Best-Link Bioscience Panelists: Jian Zhang, Director of Medical Oncology, Fudan University Shanghai Cancer Center; Anwen Xiong, Associate Chief Physician & Associate Professor, Shanghai East Hospital; Shuhang Wang, Associate Chief Physician, Cancer Hospital Chinese Academy of Sciences; Jing Li, Vice President, Mabpharm; Yun Tian, Director of Medical Service and Strategy, Novotech. Moderator: Irene Hong, Founding Partner, CEC Capital Panelists: Anna French, Managing Partner, Qiming US; Andy Liu, General Manager, Novotech. If you’d like to connect with our team in Shanghai, please schedule a meeting via the form on this page.
This event has concluded
Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.